Dipeptidyl Peptidase IV (DPP IV) Inhibitors Market Size, Share, and Industry Analysis, By Drug (Saxagliptin, Linagliptin, Empagliflozin, Sitagliptin, Alogliptin, and Others), By Type (Branded and Generic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2026-2034

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction
   1. Research Scope
   2. Market Segmentation
   3. Research Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Market Opportunities 
   4. Market Trends
4. Key Insights
   1. Prevalence of Type 2 Diabetes, By Key Countries, 2024
   2. New Product Launches/ Approvals, By Key Players
   3. Pipeline Analysis, By Key Players
   4. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
   5. Impact of COVID-19 on the Market 
5. Global Dipeptidyl Peptidase IV (DPP IV) Inhibitors Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug
      1. Saxagliptin
      2. Linagliptin
      3. Sitagliptin
      4. Alogliptin
      5. Others
   2. Market Analysis, Insights and Forecast – By Type
      1. Branded
      2. Generic
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
   4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America 
      5. Middle East & Africa
6. North America Dipeptidyl Peptidase IV (DPP IV) Inhibitors Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug
      1. Saxagliptin
      2. Linagliptin
      3. Sitagliptin
      4. Alogliptin
      5. Others
   2. Market Analysis, Insights and Forecast – By Type
      1. Branded
      2. Generic
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
   4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
7. Europe Dipeptidyl Peptidase IV (DPP IV) Inhibitors Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug
      1. Saxagliptin
      2. Linagliptin
      3. Sitagliptin
      4. Alogliptin
      5. Others
   2. Market Analysis, Insights and Forecast – By Type
      1. Branded
      2. Generic
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
   4. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
8. Asia Pacific Dipeptidyl Peptidase IV (DPP IV) Inhibitors Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug
      1. Saxagliptin
      2. Linagliptin
      3. Sitagliptin
      4. Alogliptin
      5. Others
   2. Market Analysis, Insights and Forecast – By Type
      1. Branded
      2. Generic
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
   4. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
9. Latin America Dipeptidyl Peptidase IV (DPP IV) Inhibitors Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Drug
      1. Saxagliptin
      2. Linagliptin
      3. Sitagliptin
      4. Alogliptin
      5. Others
   2. Market Analysis, Insights and Forecast – By Type
      1. Branded
      2. Generic
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
   4. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
10. Middle East & Africa Dipeptidyl Peptidase IV (DPP IV) Inhibitors Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
       1. Saxagliptin
       2. Linagliptin
       3. Sitagliptin
       4. Alogliptin
       5. Others 
    2. Market Analysis, Insights and Forecast – By Type
       1. Branded 
       2. Generic
    3. Market Analysis, Insights and Forecast – By Distribution Channel
       1. Hospital Pharmacy
       2. Retail Pharmacy
       3. Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/Sub-Region
       1. South Africa
       2. GCC
       3. Rest of Middle East & Africa
11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
       1. AstraZeneca 
       2. Bristol-Myers Squibb Company 
       3. Boehringer Ingelheim International GmbH & Co. 
       4. Eli Lilly and Company 
       5. Merck & Co., Inc. 
       6. Takeda Pharmaceutical Company Limited. 
       7. Novartis AG 
       8. Other Prominent Players